Recent news
![[International Collaborations] Exploring Issues in French and American Long-term Care Systems](https://u-paris.fr/wp-content/uploads/2022/07/3chercheurs-1-1080x675.jpg)
[International Collaborations] Exploring Issues in French and American Long-term Care Systems
© Thomas Rapp, David C. Grabowski and Bapu Jena The healthcare systems in France and the United States are different, however, since the outbreak of the global pandemic the two countries are facing common challenges. The aging populations are increasingly being...

Leiden 2022 : Université Paris Cité 1st French university for publication impact
The CTWS Leiden 2022 ranking was released on June 22nd. Published by Leiden University in the Netherlands, it is recognized for its objectivity and transparent methodology in line with research standards.

Discovering the Ikigai Method
On March 29th and April 19th 2022, the SMARTS-UP team gathered thirty graduate students for the “Ikigai” educational workshop. Led by Pascal Kolbe and Andrea Giraldo Sevilla, the workshop was based on the Japanese concept "Ikigai" of finding one’s purpose. It was the...

Welcome to Université Paris Cité !
Newly enrolled at Université Paris Cité, your student life starts now! Housing, computer equipment, healthcare… Prepare for a smooth start to the new academic year.
![[Pause] : A Programme Safeguarding Knowledge and Research](https://u-paris.fr/wp-content/uploads/2022/06/pause-1080x675.jpg)
[Pause] : A Programme Safeguarding Knowledge and Research
As part of the PAUSE programme, launched by the Collège de France, Université Paris Cité supports and welcomes researchers in difficult situations who are forced into exile by enabling them to find refuge and continue their work in France. Since 2018, more than seven...

Université Paris Cité Stands Up for LGBTQIA+ Equality
Université Paris Cité is joining forces against all forms of discrimination, including homophobia, transphobia and biphobia. It is committed to raising awareness and supporting the entire university community with regard to these issues, particularly through the...
![[Alumni portrait] Dimitri Labat, a Doctor and an Entrepreneur](https://u-paris.fr/wp-content/uploads/2022/06/Dimitri-Labat-1-1080x675.jpg)
[Alumni portrait] Dimitri Labat, a Doctor and an Entrepreneur
© Dimitri Labat Chipiron is one of the “100 startups in which to invest in 2022” of the Challenges magazine. It promises to make MRI scans (magnetic resonance imaging) – the best medical imaging technique – available to everyone everywhere. Interview with one of the...
![[International Guest Researchers] “In conversation” on Evidence Synthesis](https://u-paris.fr/wp-content/uploads/2022/06/Chaimani_Nikolakopoulou-1-1080x675.jpg)
[International Guest Researchers] “In conversation” on Evidence Synthesis
Differences in placebo effects across studies can bias the results of relative effectiveness between interventions. Evidence synthesis and network meta-analysis offer a unique opportunity to study this phenomenon.
![[International Guest Researchers Programme], In Conversation with Jean-François Cottier and Eric MacPhail](https://u-paris.fr/wp-content/uploads/2022/05/Macphail_Cottier_1920px-002-1-1080x675.jpg)
[International Guest Researchers Programme], In Conversation with Jean-François Cottier and Eric MacPhail
Jean-François Cottier, Professor at Université Paris Cité is hosting Professor Eric Macphail from Indiana University based in Bloomington, United States.

Raising Awareness through Training on Green Transition Challenges
By providing a course on Environmental Transition and Societal Issues, Université Paris Cité aims to raise awareness among the student community of the Anthropocene and planetary limitations, equip them with ideas on growth and degrowth, and...

ECOS, An Innovative, International Training Practice for Medical Students
nitiated to put skills and the doctor-patient relationship at the center of student training and evaluation, “ECOS” or “Examen Clinique Objectif et Structuré” is a situational exercise that assesses the skills and knowledge of medical students.

Become a French, Anglophone or Bilingual Volunteer at Nightline
Nightline, a listening service run by and dedicated to students, is recruiting English-speaking or bilingual volunteers, as well as French-speaking volunteers in Paris.
![[CLOVES syndrome] : The U.S. FDA approves Alpelisib based on a French study](https://u-paris.fr/wp-content/uploads/2022/04/julia-koblitz-4AsRcVTJYTw-unsplash-1080x675.jpg)
[CLOVES syndrome] : The U.S. FDA approves Alpelisib based on a French study
AP-HP, Inserm and Université Paris Cité extend their congratulations to Professor Guillaume Canaud’s teams at Necker-Enfants Malades Hospital (AP-HP), Necker-Enfants Malades Institute (INEM), Inserm, Institut Imagine and Université Paris Cité for their work on alpelisib (BYL719), approved by the US Food and Drug Administration (FDA).

Université Paris Cité awarded the “Science with and for Society” Label
On April 13th, the French Ministry of Higher Education, Research and Innovation announced the 12 new winners of the "Science with and for Society" label. (Science avec et pour la société). Université Paris Cité has joined 17 other institutions who have been granted...
![[SARS-CoV-2] Neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies](https://u-paris.fr/wp-content/uploads/2022/04/cellules-infectées-par-omicron-1080x675.jpg)
[SARS-CoV-2] Neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies
The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of...

Crowd4SDG featured at the Geneva Trialogue 2022
In the context of the Geneva Trialogue, the European research project Crowd4SDG held a hybrid workshop on March 17th called "Closing the gap between institutions and citizen science generated data and solutions". © Geneva Trialogue During the Geneva Trialogue...